Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Abstract 6169: Immunogenic cell death mediates the anticancer efficacy of high dose vitamin C
Alessandro Cavaliere, Marco Macagno, Federica Maione, Vito Amodio, Marc Escobosa Olmo, Rosaria Chilà, Simona Lamba, Pietro Paolo Vitiello, Valeria Pessei, Daniela Grases, Elena Escolano Pérez, Alice Bartolini, Noemi Congiusta, Giovanni Germano, Andrea Sartore‐Bianchi, Teresa Troiani, Manel Esteller, Eduard Porta‐Pardo, Alberto Bardelli, Federica Di Nicolantonio (2025). Abstract 6169: Immunogenic cell death mediates the anticancer efficacy of high dose vitamin C. , 85(8_Supplement_1), DOI: https://doi.org/10.1158/1538-7445.am2025-6169.
Article180 days agoDiscovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
Ludovic Barault, Alessio Amatu, Giulia Siravegna, Agostino Ponzetti, Sebastián Morán, Andrea Cassingena, Benedetta Mussolin, Chiara Falcomatà, Alexandra M. Binder, Carmen Cristiano, Daniele Oddo, Simonetta Guarrera, Carlotta Cancelliere, Sara Bustreo, Katia Bencardino, Sean K. Maden, Alice Vanzati, Patrizia Zavattari, Giuseppe Matullo, Mauro Truini, William M. Grady, Patrizia Racca, Karin B. Michels, Salvatore Siena, Manel Esteller, Alberto Bardelli, Andrea Sartore‐Bianchi, Federica Di Nicolantonio (2017). Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. , 67(11), DOI: https://doi.org/10.1136/gutjnl-2016-313372.
Article180 days agoTumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer
Alessio Amatu, Ludovic Barault, Cátia Moutinho, Andrea Cassingena, Katia Bencardino, Silvia Ghezzi, Laura Palmeri, Erica Bonazzina, Federica Tosi, Riccardo Ricotta, Tiziana Cipani, Patrizia Crivori, Rosalinda Gatto, Giuseppe Chirico, Giovanna Marrapese, Mauro Truini, Alberto Bardelli, Manel Esteller, Federica Di Nicolantonio, Andrea Sartore‐Bianchi, Salvatore Siena (2016). Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer. , 27(6), DOI: https://doi.org/10.1093/annonc/mdw071.
Article180 days agoDiscovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
Ludovic Barault, Alessio Amatu, Giulia Siravegna, Agostino Ponzetti, Sebastián Morán, Andrea Cassingena, Benedetta Mussolin, Chiara Falcomatà, Alexandra M. Binder, Carmen Cristiano, Daniele Oddo, Simonetta Guarrera, Carlotta Cancelliere, Sara Bustreo, Katia Bencardino, Sean K. Maden, Alice Vanzati, Patrizia Zavattari, Giuseppe Matullo, Mauro Truini, William M. Grady, Patrizia Racca, Karin B. Michels, Salvatore Siena, Manel Esteller, Alberto Bardelli, Andrea Sartore‐Bianchi, Federica Di Nicolantonio (2017). Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. , 67(11), DOI: https://doi.org/10.1136/gutjnl-2016-313372.
Article180 days agoPhase II study of temozolomide (TMZ) in metastatic colorectal cancer (mCRC) patients molecularly selected by MGMT promoter hypermethylation.
Alessio Amatu, Katia Bencardino, Ludovic Barault, Andrea Cassingena, Erica Bonazzina, Silvia Ghezzi, Cátia Moutinho, Federica Tosi, Riccardo Ricotta, Elena Magni, Rosalinda Gatto, Giovanna Marrapese, Manel Esteller, Alberto Bardelli, Federica Di Nicolantonio, Andrea Sartore‐Bianchi, Salvatore Siena (2015). Phase II study of temozolomide (TMZ) in metastatic colorectal cancer (mCRC) patients molecularly selected by MGMT promoter hypermethylation.. , 33(3_suppl), DOI: https://doi.org/10.1200/jco.2015.33.3_suppl.583.
Article180 days ago